Early-stage funds often publish lists of project ideas they would be willing to invest in. The most famous example, "Request for Startups" from YC, can be seen here. And another one.
Why might such a project be stronger than a random idea? Funds see the wide picture — a view of the entire market — while founders see deep but narrow. Usually they don't step beyond a single vertical: the one they studied or worked in at their previous job. As a result, potentially strong founders walk past huge markets and build services for 100 users, losing years of their lives.
RFS helps founders:
- improve their odds of building a truly large business;
- secure financing (no need to write to 200 funds if there are 2 strongly interested ones);
- get strong feedback (such a fund has deep expertise in this specific area, and it's probably worth listening).
The fund is interested in:
- receiving 50 targeted pitches instead of 500 random ones;
- talking to strong "builders" rather than professional "pitchers" with polished slides;
- not buying a "lottery ticket" or "index of the entire market," but focusing on target verticals.
The best way to predict the future is to create it. Forza is highly likely to invest in these projects, provided the team and execution plan are strong.
The list of projects is updated frequently.
- Home bloodwork OS
- Subscription + logistics + interpretation of test results + automated correction protocols (iron, B12, inflammation, lipids) under physician supervision.
- Unclear how to maintain high margin with (a) home visits (especially if patients have to wait 2 hours for IV drips), (b) operating under someone else's license.
- California is enough at the start.
- Early cancer detection
- Subscription business model. A service that combines multi-cancer screening (blood/tests/imaging), reminders, and navigation through diagnostics.
- Unclear how to solve the false-positive problem (a service that produces 10 false positives per nurse visit and scares patients to death is not viable). Quite possibly, the problem cannot be solved without technology breakthroughs.
- California is enough at the start.
- Hormone optimization platform
- A transparent, medically valid platform for hormonal health (men/women) where the result is measured by objective markers. Evidence-based medicine, no charlatanism.
- The challenge — how to keep high margin while operating under a lead-generation model (without a license)? We assume the service will start "giving advice", which requires obtaining a license (how would you get it fast/cheaply?).
- California is enough at the start.
- Geo-arbitrage in expensive medical procedures
- The difficulty isn't in the products (there are dozens of procedures where the price gap between the US and Europe/Mexico is $30K+), but in finding enough customers willing to pay (people who are not rich enough to ignore the price difference, but rich enough to pay without insurance).
- The second problem — advertising restrictions.
- US only.
- AI talent scout (next-gen recruiting)
- Not "resume matching," but an agent that searches for people everywhere, evaluates real skills, writes to them, runs the conversation, and closes the hire.
- There are already many alternatives — what makes this one better?
- The task is hard, but we're fighting for a high check (one annual salary of the candidate, ~$80K per client).
- US only.
- Digital copy of a person
- Not just preserving information (correspondence, video, interviews, transcripts of every conversation). Not just chat/video you can talk to. The next level.
- Family offices
- Solutions for UHNWI managers. The value should be measured in millions of dollars, not "slides got prettier and faster to make."